Literature DB >> 24102999

Increased pituitary volume in subjects at risk for psychosis and patients with first-episode schizophrenia.

Tsutomu Takahashi1, Kazue Nakamura, Shimako Nishiyama, Atsushi Furuichi, Eiji Ikeda, Mikio Kido, Yumiko Nakamura, Yasuhiro Kawasaki, Kyo Noguchi, Hikaru Seto, Michio Suzuki.   

Abstract

AIM: Enlarged pituitary gland has been reported in schizophrenia, possibly reflecting hypothalamic-pituitary-adrenal hyperactivity. The aim of the present study was to examine whether individuals at risk of psychosis also have similar changes.
METHODS: Magnetic resonance imaging was used to examine the pituitary volume in 22 individuals with at-risk mental state (ARMS; 11 male, 11 female), 64 first-episode patients with schizophrenia (FESz; 37 male, 27 female), and 86 healthy controls. The control subjects were divided into age- and gender-matched controls for ARMS (11 male, 11 female) and FESz (37 male, 27 female).
RESULTS: Both the ARMS and FESz groups had a larger pituitary volume compared with matched controls, but no difference was found between the ARMS and FESz subjects. There was no association between the pituitary volume and clinical variables (symptommeasures at scanning, daily dosage or duration of antipsychotic medication) in either clinical group. The pituitary volume did not differ significantly between the ARMS individuals who later developed schizophrenia (n = 5) and those who did not (n = 17). The pituitary volume was larger in women than in men for all diagnostic groups.
CONCLUSION: The finding of increased pituitary volume in both ARMS and FESz subjects may reflect a common vulnerability to stress in early psychosis. Further work in a larger ARMS sample is required to examine the possible relationship between pituitary volume and emergence of psychosis.
© 2013 The Authors. Psychiatry and Clinical Neurosciences © 2013 Japanese Society of Psychiatry and Neurology.

Entities:  

Keywords:  at-risk mental state; hypothalamic-pituitary-adrenal axis; magnetic resonance imaging; pituitary gland; schizophrenia

Mesh:

Substances:

Year:  2013        PMID: 24102999     DOI: 10.1111/pcn.12093

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  5 in total

Review 1.  Molecular substrates of schizophrenia: homeostatic signaling to connectivity.

Authors:  M A Landek-Salgado; T E Faust; A Sawa
Journal:  Mol Psychiatry       Date:  2015-09-22       Impact factor: 15.992

Review 2.  Diverse definitions of the early course of schizophrenia-a targeted literature review.

Authors:  Richard Newton; Alice Rouleau; Anna-Greta Nylander; Jean-Yves Loze; Henrike K Resemann; Sara Steeves; Benedicto Crespo-Facorro
Journal:  NPJ Schizophr       Date:  2018-10-15

3.  Pituitary Volume and Socio-Cognitive Functions in Individuals at Risk of Psychosis and Patients With Schizophrenia.

Authors:  Tsutomu Takahashi; Yuko Higuchi; Yuko Komori; Shimako Nishiyama; Yoichiro Takayanagi; Daiki Sasabayashi; Mikio Kido; Atsushi Furuichi; Yumiko Nishikawa; Mihoko Nakamura; Kyo Noguchi; Michio Suzuki
Journal:  Front Psychiatry       Date:  2018-11-09       Impact factor: 4.157

Review 4.  Effects of inflammation on the kynurenine pathway in schizophrenia - a systematic review.

Authors:  Bruno Pedraz-Petrozzi; Osama Elyamany; Christoph Rummel; Christoph Mulert
Journal:  J Neuroinflammation       Date:  2020-02-15       Impact factor: 8.322

Review 5.  Toward earlier identification and preventative intervention in schizophrenia: evidence from the London Child Health and Development Study.

Authors:  Kristin R Laurens; Alexis E Cullen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-12-15       Impact factor: 4.328

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.